Author: Khalil, Ayman; Tazeddinova, Diana
Title: The upshot of Polyphenolic compounds on immunity amid COVID-19 pandemic and other emerging communicable diseases: An appraisal Cord-id: e3pazjdi Document date: 2020_10_15
ID: e3pazjdi
Snippet: Polyphenols are a large family of more than 10,000 naturally occurring compounds, which exert countless pharmacological, biological and physiological benefits for human health including several chronic diseases such as cancer, diabetes, cardiovascular, and neurological diseases. Their role in traditional medicine, such as the use of a wide range of remedial herbs (thyme, oregano, rosemary, sage, mint, basil), has been well and long known for treating common respiratory problems and cold infectio
Document: Polyphenols are a large family of more than 10,000 naturally occurring compounds, which exert countless pharmacological, biological and physiological benefits for human health including several chronic diseases such as cancer, diabetes, cardiovascular, and neurological diseases. Their role in traditional medicine, such as the use of a wide range of remedial herbs (thyme, oregano, rosemary, sage, mint, basil), has been well and long known for treating common respiratory problems and cold infections. This review reports on the most highlighted polyphenolic compounds present in up to date literature and their specific antiviral perceptive properties that might enhance the body immunity facing COVID-19, and other viral infectious diseases. In fact, several studies and clinical trials increasingly proved the role of polyphenols in controlling numerous human pathogens including SARS and MERS, which are quite similar to COVID-19 through the enhancement of host immune response against viral infections by different biological mechanisms. Thus, polyphenols ought to be considered as a potential and valuable source for designing new drugs that could be used effectively in the combat against COVIDâ€19 and other rigorous diseases.
Search related documents:
Co phrase search for related documents- activation pathway and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- activation pathway and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- activation pathway and acute lung injury ameliorate: 1, 2
- activation pathway and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66
- activation pathway and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9
- activation pathway and additional study: 1, 2, 3
- activation pathway and adenovirus type: 1
- activation pathway and adhesion molecule: 1, 2, 3, 4, 5
- activation pathway and liver inflammation: 1, 2
- activation pathway and liver injury: 1, 2, 3, 4, 5, 6
- activation pathway and lps induce: 1
- activation pathway and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- activation pathway and lung dysfunction: 1, 2
- activation pathway and lung function: 1, 2, 3, 4, 5, 6
- activation pathway and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- activation pathway and lung inflammatory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- activation pathway and lung kidney: 1, 2, 3, 4, 5
- activation pathway and macrophage inflammation: 1, 2, 3
- activation pathway and madin darby: 1
Co phrase search for related documents, hyperlinks ordered by date